German Hospital: Putin Critic Alexei Navalny Remains In Coma

25 August 2020, Berlin: The bed skyscraper of the Berliner Charite can be seen behind the Reichstag building (photographed through a window pane). In the clinic the Russian oppositional Nawalny is treated. Doctors of the Berliner Charite assume that the Kremlin critic was poisoned. Photo: Christoph Soeder/dpa
The bed skyscraper of the Berliner Charite can be seen behind the Reichstag building in Berlin, Germany, Tuesday, Aug.25, 2020.. In the clinic the Russian oppositional Nawalny is treated. Doctors of the Berliner Char... The bed skyscraper of the Berliner Charite can be seen behind the Reichstag building in Berlin, Germany, Tuesday, Aug.25, 2020.. In the clinic the Russian oppositional Nawalny is treated. Doctors of the Berliner Charite assume that the Kremlin critic was poisoned. (Christoph Soeder/dpa via AP) MORE LESS
|
August 28, 2020 9:22 a.m.

BERLIN (AP) — German doctors treating Russian opposition leader Alexei Navalny for a suspected poisoning say the dissident is still in an induced coma but his condition is stable and his symptoms are improving.

Navalny, a corruption investigator who is one of Russian President Vladimir Putin’s fiercest critics, fell ill on a flight back to Moscow from Siberia about a week ago and was taken to a hospital in the Siberian city of Omsk after the plane made an emergency landing.

Last weekend, he was transferred to the Charité hospital in Berlin, where doctors found indications of “cholinesterase inhibitors” in his system. Found in some drugs, pesticides and chemical nerve agents, cholinesterase inhibitors block the breakdown of a key chemical in the body, acetycholine, that transmits signals between nerve cells.

He is being treated with the antidote atropine. Charité said Friday that “there has been some improvement in the symptoms caused by the inhibition of cholinesterase activity.”

“While his condition remains serious, there is no immediate danger to his life,” the hospital said. “However, due to the severity of the patient’s poisoning, it remains too early to gauge potential long-term effects.”

Support The TPM Journalism Fund
  • Contributions allow us to hire more journalists
  • Contributions allow us to provide free memberships to those who cannot afford them
  • Contributions support independent, non-corporate journalism
Comments
advertisement
Masthead Masthead
Founder & Editor-in-Chief:
Executive Editor:
Managing Editor:
Senior Editor:
Special Projects Editor:
Editor at Large:
General Counsel:
Publisher:
Head of Product:
Director of Technology:
Associate Publisher:
Front-End Developer:
Senior Designer:
SPECIAL DEAL FOR PAST TPM MEMBERS
40% OFF AN ANNUAL PRIME MEMBERSHIP
REJOIN FOR JUST $30